Insider · CIK 0001814093

Bisker-Leib Vered

Reports to the SEC for 3 companies · REHOVOT, L3

sec.gov

Transactions

Companies

Filings

CIK

0001814093

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-08	CMPXCompass Therapeutics, Inc.F Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−49.2K sh	$1.45	−$71.3K	3,124,426
2024-01-09	CMPXCompass Therapeutics, Inc.A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+1.75M sh	$1.93	+$3.38M	3,173,624
2024-01-09	CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+1.75M sh	—	—	1,753,125
2023-11-17	CMPXCompass Therapeutics, Inc.F Tax Payment	Director, CHIEF EXECUTIVE OFFICER	FTax Payment	−64.4K sh	$1.50	−$96.6K	1,420,499
2023-02-08	CMPXCompass Therapeutics, Inc.A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+400K sh	—	—	1,484,914
2023-02-08	CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+600K sh	—	—	600,000
2023-01-19	Old Ayala, IncStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,250 sh	—	—	0
2023-01-19	Old Ayala, IncStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,750 sh	—	—	0
2023-01-19	Old Ayala, IncStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,250 sh	—	—	0
2023-01-19	Ayala Pharmaceuticals, Inc.Stock OptionA Award	Director	AAward	+1,639 sh	—	—	1,639
2023-01-19	Ayala Pharmaceuticals, Inc.Stock OptionA Award	Director	AAward	+1,171 sh	—	—	1,171
2023-01-19	Ayala Pharmaceuticals, Inc.Stock OptionA Award	Director	AAward	+1,171 sh	—	—	1,171
2022-11-25	CMPXCompass Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−2 sh	$4.36	−$8.72	1,060,414
2022-11-23	CMPXCompass Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−9,569 sh	$4.30	−$41.1K	1,060,416
2022-11-22	CMPXCompass Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−14.9K sh	$4.19	−$62.6K	1,069,985
2022-11-21	CMPXCompass Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−16K sh	$4.34	−$69.6K	1,084,914
2022-11-18	CMPXCompass Therapeutics, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−6,226 sh	$4.40	−$27.4K	1,107,175
2022-06-13	Old Ayala, IncStock Option (Right to Buy)A Award	Director	AAward	+6,250 sh	—	—	6,250
2022-02-18	CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+500K sh	—	—	500,000
2022-02-17	CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+500K sh	—	—	500,000
2021-11-16	CMPXCompass Therapeutics, Inc.A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+600K sh	—	—	1,113,401
2021-06-10	Old Ayala, IncStock Option (Right to Buy)A Award	Director	AAward	+6,250 sh	—	—	6,250
2021-02-09	CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+400K sh	—	—	400,000
2020-08-18	Old Ayala, IncStock Option (Right to Buy)A Award	Director	AAward	+8,750 sh	—	—	8,750
2020-08-06	CMPXCompass Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+600K sh	—	—	600,000

Recent filings

Accepted (ET)
Feb 94
Bisker-Leib Vered0001171843-24-000715
SEC(opens sec.gov)
Jan 104
Bisker-Leib Vered0001171843-24-000179
SEC(opens sec.gov)
Nov 214
Bisker-Leib Vered0001171843-23-007223
SEC(opens sec.gov)
Feb 94
Bisker-Leib Vered0001171843-23-000846
SEC(opens sec.gov)
Jan 234
Bisker-Leib Vered0001213900-23-004538
SEC(opens sec.gov)
Jan 234
Bisker-Leib Vered0001493152-23-002243
SEC(opens sec.gov)
Nov 254
Bisker-Leib Vered0001171843-22-007662
SEC(opens sec.gov)
Nov 224
Bisker-Leib Vered0001171843-22-007635
SEC(opens sec.gov)
Jun 154
Bisker-Leib Vered0000899243-22-022558
SEC(opens sec.gov)
Feb 234/A
Bisker-Leib Vered0000899243-22-007413
SEC(opens sec.gov)
Feb 184
Bisker-Leib Vered0001171843-22-001210
SEC(opens sec.gov)

Companies

Address

OPPENHEIMER 4

REHOVOT, L3, 7670104